Home / Hematology
Hematology
| 1 min read
Elan Corp. and Wyeth Pharmaceuticals, a division of Wyeth, recently announced the first patient in North America has been dosed as part of a global Phase III clinical program
| 2 min read
Eli Lilly and Co. is funding research of diabetes biomarkers through a $3 million grant to the Juvenile Diabetes Research Foundation.
| 2 min read
Vitae and Boehringer Ingelheim pair up to advance an inhibitor with promise to treat diabetes and other related disease states
| 1 min read
Annually, upward of a half-million people suffer from septic infections that require aggressive and intensive treatment and cost the economy $10 billion directly and indirectly.
| 1 min read
Getting a therapeutic to the target organ or tissue is only half the battle for most diseases, as most drugs need to be internalized by the affected cells to be effective.
| 1 min read
therapy specialist VIRxSYS announced it had acquired all core technology and preclinical programs of Intronn, Inc.
| 1 min read
Biotage enters into joint R&D work at McMaster U to expand into molecular imaging
| 2 min read
Enzo Biochem Inc. announced late last month that its wholly owned subsidiary, Enzo Life Sciences Inc., signed a definitive agreement to acquire Axxora Life Sciences Inc., a privately owned global manufacturer and marketer of life sciences research products, for approximately $16.3 million in cash
